Drug name - Zontivity

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7304078 XSPIRE PHARMA Thrombin receptor antagonists
Apr, 2024

(1 year, 7 months from now)

US7713999 XSPIRE PHARMA Thrombin receptor antagonists
May, 2024

(1 year, 9 months from now)

More Information on Dosage
Strength Dosage Availability
EQ 2.08MG BASE TABLET;ORAL Prescription